Spiritual Faith and Genetic Testing Decisions among High-Risk Breast Cancer Probands
Despite widespread access to genetic testing for the BRCA1 and BRCA2 breast cancer susceptibility genes, little is known about rates or predictors of test use among individuals from newly ascertained high-risk families who have self-referred for genetic counseling/testing. The objective of this stud...
Gespeichert in:
Veröffentlicht in: | Cancer epidemiology, biomarkers & prevention biomarkers & prevention, 2000-04, Vol.9 (4), p.381-385 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Despite widespread access to genetic testing for the BRCA1
and BRCA2 breast cancer susceptibility genes, little is
known about rates or predictors of test use among individuals from
newly ascertained high-risk families who have self-referred for genetic
counseling/testing. The objective of this study was to examine rates of
test use within this population. In addition, we sought to determine
whether spiritual faith and psychological factors influenced testing
decisions. Participants were 290 women with familial breast cancer. All
were offered genetic counseling and testing for alterations in the
BRCA1 and BRCA2 genes. Baseline levels of
spiritual faith, cancer-specific distress, perceived risk, and
demographic factors were examined to identify independent predictors of
whether participants received versus declined testing. The
final logistic model revealed statistically significant main effects
for spiritual faith [odds ratio (OR), 0.2; 95% confidence intervals
(CIs), 0.1 and 0.5] and perceived ovarian cancer risk (OR, 2.4; 95%
CIs, 1.3 and 4.7) and a statistically significant spiritual faith by
perceived risk interaction effect. Among women who perceived themselves
to be at low risk of developing breast cancer again, those with higher
levels of spiritual faith were significantly less likely to be tested,
compared with those with lower levels of faith (OR, 0.2; 95% CIs, 0.1
and 0.5). However, among women with high levels of perceived risk,
rates of test use were high, regardless of levels of spiritual faith
(OR, 1.2; 95% CIs, 0.4 and 3.0). These results highlight the role that
spirituality may play in the decision-making process about genetic
testing. |
---|---|
ISSN: | 1055-9965 1538-7755 |